查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球渠道止血市場-2022-2029
市場調查報告書
商品編碼
1129262

全球渠道止血市場-2022-2029

Global Channel Coagulometer Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 160 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場動態

渠道止血的創新有望推動市場增長。

由 Medsource Ozone Biomedicals 創建的現代 4 通道光凝分析儀具有觸摸屏界面，用戶舒適，並採用最新的血栓檢測技術。

此外，2021 年 10 月 20 日，在凝血領域推出了一種革命性的新產品，以提高臨床表現和生產力。 Diagon Ltd. 的凝血分析儀產品的首次亮相是由著名的醫療設備供應商 Trivitron Healthcare 宣布的。簽署合作協議後，Trivitron 宣布與 Diagon-Vanguard Diagnostics India 合作為印度診斷市場推出這些產品。此次發布對醫學界來說是個好兆頭，因為它擴大了患者管理並提高了臨床決策的有效性。匈牙利對角線生產的COAG線自動和半自動POC系統是新產品之一。它們用於評估抗凝劑和止血治療的功效，並降低各種手術過程中的出血風險。因此，從上述陳述來看，預計市場將在預測期內受到驅動。

約束

分析儀的高成本、嚴格的監管審批以及缺乏管理分析儀的熟練專業人員可能是在預測期內阻礙市場的因素。

行業分析

渠道止血市場根據供應鏈、定價分析和監管分析等各種行業因素對市場進行深入分析。

COVID-19 影響分析

COVID-19 大流行對市場產生了適度的影響。了解大流行期間與 COVID-19 凝血病相關的出血和血栓事件的頻率以及凝血病檢測在確定出血或血栓形成的可能性和疾病嚴重程度的臨床價值是極其重要的。除 D-二聚體外，凝血□原時間 (PT) 的延長也與生存率下降和危重患者管理的需要有關。彌散性血管內凝血 (DIC) 與超過 70% 的患者因感染死亡有關，並且已根據實驗室結果進行了描述。因此，渠道聚合器的需求量越來越大。同時，COVID-19 削弱了供應鏈，並造成全球渠道聚合器產品短缺。因此，COVID-19 大流行正在影響市場。但是，預計這種情況將在預測期內逐漸改善。

全球渠道止血市場報告將提供對大約 45 多個市場數據表、40 多個數字和 160 頁的訪問。

內容

第一章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第 4 章市場動態

  • 市場影響因素
    • 驅動程序
      • 渠道聚合器的創新有望推動市場增長。
    • 限制因素
      • 分析設備的高成本預計將在預測期內受到阻礙。
    • 機會
    • 影響分析

第五章行業分析

  • 波特的五種力量
  • 未滿足的需求
  • 供應鏈
  • 定價分析

第 6 章 COVID-19 分析

  • COVID-19 的市場分析
    • COVID-19 發布前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按產品類型

  • 2 通道血凝儀
  • 4 通道血凝儀
  • 6 通道血凝儀
  • 7 通道血凝儀
  • 8 通道血凝儀

第 8 章按模態類型

  • 獨立的血凝儀
  • 台式血凝測量儀
  • 手持式/便攜式血凝儀
  • 其他

第 9 章，最終用戶

  • 醫院
  • 學術和研究機構
  • 委託研究機構
  • 診斷機構
  • 其他

第 10 章按地區劃分

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 11 章競爭格局

  • 主要發展和戰略
  • 公司份額分析
  • 產品基準
  • 值得關注的重點公司列表

第 12 章公司簡介

  • HORIBA Medical
    • 公司概況
    • 產品組合和描述
    • 主要亮點
    • 財務摘要
  • LINEAR CHEMICALS S.L.U.
  • BioSystems S.A.
  • Rayto Life and Analytical Sciences Co.,Ltd.
  • Micro Lab Instruments
  • TECO Medical Instruments
  • Helena Biosciences
  • Genrui Biotech Inc.
  • Biobase
  • Maccura Biotechnology Co., Ltd.

第 13 章全球渠道止血市場 - DataM

簡介目錄
Product Code: DMCD5847

Market Overview

Channel Coagulometer Market size was valued US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of YY % during the forecast period (2022-2029).

A blood coagulometer is an analyzer used to test the coagulation efficiency of blood to diagnose and assess bleeding disorders such as hemophilia or monitor patients taking anticoagulant medicines such as aspirin, heparin, or warfarin. There are six to seven different kinds, including the two-channel coagulometer, four-channel coagulometer, six-channel coagulometer, seven-channel coagulometer, and eight-channel coagulometer, and so on. Moreover, it also assists doctors in developing individualized antiplatelet therapy.

Market Dynamics

Innovations in the channel coagulometer are expected to drive market growth.

A modern four-channel photo-optical coagulation analyzer created by Medsource Ozone Biomedicals features a touch screen interface for user comfort latest clot detection technology. Three reagent stations and 22 sample positions for incubation, automatic optical start, LED technology Results in INR, Ratio, Quick%, Low reagent and sample volume required, no bars or stirrers needed, an instrument that requires no upkeep Can perform four tests at once (simultaneously), Compatibility with PT, aPTT, TT, FIB, D-Dimer, Factors, Protein C, Protein S, and essentially any Hemostasis assay, etc. Observations from 180 patients.

Moreover, an innovative new product was launched in the Coagulation segment on October 20, 2021, to improve clinical outcomes and productivity. The debut of a new line of Coagulation Analyzer products made by Diagon Ltd. has been announced by Trivitron Healthcare, a prominent provider of medical devices. After signing a collaboration agreement, Trivitron announced the launch of these products for the Indian diagnostics market in collaboration with Diagon-Vanguard Diagnostics India. This launch bodes well for the medical community because it expands patient management and improves clinical decision-making effectiveness. The COAG Line automated, semi-automated, and POC systems produced by Diagon Hungary are among the new products. They are used to assess the effectiveness of anticoagulant medications and hemostatic therapy and to reduce the risk of bleeding during extensive procedures. Thus, from the above statements, the market is expected to drive in the forecast period.

Restraint:

The high cost of the analyzers, stringent regulatory approvals, and lack of skilled professionals for managing the analyzers are the factors the market is expected to get hampered in the forecast period.

Industry Analysis

The channel coagulometer market provides in-depth analysis of the market based on various industry factors such as supply chain, pricing analysis, regulatory analysis etc.

COVID-19 Impact Analysis

The COVID-19 pandemic has moderately impacted the market. During the pandemic, it is crucial to comprehend the frequency of bleeding and thrombotic symptoms linked to COVID-19 coagulopathy, as well as the clinical value of abnormal coagulation testing to identify the likelihood of bleeding, thrombosis, and the severity of the sickness. Besides D-dimer, a prolonged prothrombin time (PT) has also been linked to a lower chance of survival and a greater demand for critical care. Disseminated intravascular coagulation (DIC), linked to >70% of patients who die from the infection, has been described based on test results. As a result, the channel coagulometer is now more in demand. In contrast, COVID-19 has weakened the supply chain and created a global shortage of channel coagulometer products. Thus, the COVID-19 pandemic has affected the market. However, the situation is expected to improve gradually in the forecast period.

Segment Analysis

Hospital segment is expected to hold the largest market share in channel coagulometer market.

The hospital segment accounted for the largest market share in 2021. The increasing number of hospitals and their growing infrastructure are the factors to drive the market growth. For instance, in 2020, Colombia had the highest hospital count, around 10,899. In comparison, Japan had around 8,238 hospitals. Moreover, as of November 18, 2021, 80,136 Ayushman Bharat-Health and Wellness Centres (AB-HWCs) are operational in India. As of November 18, 2021, 638 e-Hospitals are established across India as part of the central government's 'Digital India' initiative. Therefore, it has led to increasing demand for channel coagulometers. Thus, from the above statements, the market segment accounted for the largest market share in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global channel coagulometer market

In 2021, the North American channel coagulometer accounted for the highest revenue share in the global market. The increasing prevalence of blood clotting-related disorders, technological advancement in the channel coagulometer, well-established infrastructure, and product launches by the key market players are the factors that drive the market in the forecast period. For instance, Von Willebrand disease, the most prevalent genetic bleeding disorder in America brought on by clotting proteins, affects a lot more people. Both sexes are susceptible to Von Willebrand disease. Moreover, the most common inherited bleeding disorder among American women is a common cause of heavy menstrual bleeding and other bleeding problems in women and adolescent girls. Therefore, it has increased the demand for channel coagulometers in the region; thus, the North American region has the largest market share.

Competitive Landscape

Major key players in the channel coagulometer market are HORIBA Medical, LINEAR CHEMICALS S.L.U., BioSystems S.A., Rayto Life and Analytical Sciences Co.,Ltd., Micro Lab Instruments, TECO Medical Instruments, Helena Biosciences, Genrui Biotech Inc., Biobase and Maccura Biotechnology Co., Ltd.

Micro Lab Instruments:

Overview:

Micro Lab Instruments is one of India's fastest-growing diagnostic companies based in Ahmedabad, the Western state of India, established in 1993. The company manufacturers and exporters a wide range of Biochemistry Analyzer, Electrolyte Analyzer, Elisa Reader, Dry Bath Incubator, Elisa Plate Washer, Single Channel coagulometers and much more. The organization is supported by a team of experienced professionals, which directs its sincere and painstaking efforts to provide its customers with the best solution for their needs. Moreover, the company exports its products to countries including Egypt, Peru, Ethiopia, South Africa and Kenya.

Product Portfolio:

Single Channel Coagulometer:

Main Features:

  • Semi-automatic Single channel coagulometer
  • Printout of the graph and results
  • On-board storage capability up to 20 assays
  • Open system with user friendly software
  • All methods creatable, editable, copy and delete
  • Automated calculation results in seconds, %, INR, g/l, mg/dl, Ratio
  • Calibration/reference curves editable up to 9 measurement points
  • Automatic start-pipette connectable
  • Automated cuvette detection and calculation
  • Data transmission to SD-card or external PC (Optional)

The global channel coagulometer market report would provide an access to an approx. 45+market data table, 40+figures and 160pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Innovations in the channel coagulometer are expected to drive market growth.
    • 4.1.2. Restraints:
      • 4.1.2.1. The high cost of the analyzers is expected to get hampered in the forecast period.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces
  • 5.2. Unmet Needs
  • 5.3. Supply Chain
  • 5.4. Pricing Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type Segment
  • 7.2. 2 Channel Coagulometer*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. 4 Channel Coagulometer
  • 7.4. 6 Channel Coagulometer
  • 7.5. 7 Channel Coagulometer
  • 7.6. 8 Channel Coagulometer

8. By Modality Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
    • 8.1.2. Market Attractiveness Index, By Modality Type Segment
  • 8.2. Stand-Alone Coagulometer*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Bench-Top Coagulometer
  • 8.4. Handhled/Protable Coagulometer
  • 8.5. Others

9. By End user

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 9.1.2. Market Attractiveness Index, By End user Segment
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Academic & Research Institutions
  • 9.4. Contract Research Organization
  • 9.5. Diagnostic Laboratories
  • 9.6. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user

11. Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Product Benchmarking
  • 11.4. List of Key Companies to Watch

12. Company Profiles

  • 12.1. HORIBA Medical*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. LINEAR CHEMICALS S.L.U.
  • 12.3. BioSystems S.A.
  • 12.4. Rayto Life and Analytical Sciences Co.,Ltd.
  • 12.5. Micro Lab Instruments
  • 12.6. TECO Medical Instruments
  • 12.7. Helena Biosciences
  • 12.8. Genrui Biotech Inc.
  • 12.9. Biobase
  • 12.10. Maccura Biotechnology Co., Ltd.

LIST NOT EXHAUSTIVE

13. Global Channel Coagulometer Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and Applications
  • 13.3. Contact Us